Psychologists in Bogart, GA Accepting Medicare
5 Psychologists found. Showing 1 - 5
 Dr. Toni L Mason, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1361 Jennings Mill Rd, Suite 201, Bogart, GA 30622 Phone: 706-316-1908 Fax: 706-316-2062 |
Dr. Janet Stillman Martin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1551 Jennings Mill Rd, Bogart, GA 30622 Phone: 706-338-9551 Fax: 706-549-3596 |
Dr. Anna M Edwards-gaura, PH.D. Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 182 Ben Burton Cir, Suite 100, Bogart, GA 30622 Phone: 706-995-3160 |
Dr. Marie Elizabeth Williams, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3001 Monroe Hwy, Ste 600 C, Bogart, GA 30622 Phone: 706-224-0012 |
Dr. Pamela Ann Taylor, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 1551 Jennings Mill Rd, Suite 2000b, Bogart, GA 30622 Phone: 706-372-6055 Fax: 706-354-6972 |
News Archive
New risk stratification models could assist COVID-19 management
A novel study appearing as a preprint on the medRxiv server describes the performance of a new risk prediction model based on a wide range of patient variables for death and intensive care unit (ICU) admission.
Ulcerative colitis drug market to grow up to $2.1 billion in 2018
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the ulcerative colitis drug market will nearly double from $1.2 billion in 2008 to $2.1 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Study brings opportunities of personalised therapy for breast cancer a step closer
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination
New research from a team of scientists in Australia finds that the second ‘booster' dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). The results suggest one dose of the vaccine was sufficient in providing a robust immune response 11 days after inoculation.
Lithera commences LIPO-202 Phase 2b trial for reduction of subcutaneous fat
Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, announced today that the first patient has been treated with LIPO-202 (Salmeterol Xinafoate for Injection) in its 500-patient Phase 2b "RESET" trial.
› Verified 8 days ago
Pharmacists
Counselors
Dentists
Occupational Therapists
Clinical Social Workers
Psychologists